Reduced Content of Gluten Diet on Patients With Irritable Bowel Syndrome (Pro.Ali.Fun.)
Conditions:   Irritable Bowel Syndrome;   Gluten Sensitivity Intervention:   Dietary Supplement: Reduced gluten bread and Pasta compared o normal gluten bread and Pasta Sponsor:   University of Bari Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 20, 2018 Category: Research Source Type: clinical trials

The Predictive Value of Alarm Symptoms in Patients With Irritable Bowel Syndrome Based on Rome IV
Condition:   Irritable Bowel Syndrome Intervention:   Sponsor:   Second Affiliated Hospital of Xi'an Jiaotong University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2018 Category: Research Source Type: clinical trials

Fecal Microbiota Transplantation for Irritable Bowel Syndrome
Conditions:   Irritable Bowel Syndrome;   Fecal Microbiota Transplantation Interventions:   Procedure: fecal microbiota transplantation;   Procedure: Infusion of sham;   Drug: probiotics, antibiotics or antidepressants Sponsor:   Guangzhou First People's Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 3, 2018 Category: Research Source Type: clinical trials

Efficacy and Safety of Plecanatide in Children 6 to < 18 Years of Age With Irritable Bowel Syndrome With Constipation (IBS-C)
Condition:   Irritable Bowel Syndrome With Constipation Interventions:   Drug: Plecanatide;   Drug: Matching placebo Sponsor:   Synergy Pharmaceuticals Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 24, 2018 Category: Research Source Type: clinical trials

Efficacy and indication optimization of Chinese medicine ( Tiao-Chang Ke-Min granules) for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial
DiscussionThis trial may provide high-quality evidence on the efficacy and safety of TCKM granules for IBS and a more accurate indication. Importantly, this trial will provide a new research method for improving the therapeutic effects of CM for clinicians and researchers. To address IBS relapse assessment, a series of special definitions of relapse incidents has been made for this trial.Trial registrationChinese Clinical Trial Registry, ID:ChiCTR-IOR-17010600. Registered on 9 February 2017. (Source: Trials)
Source: Trials - July 11, 2018 Category: Research Source Type: clinical trials

A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation
Condition:   Irritable Bowel Syndrome Characterized by Constipation Interventions:   Drug: Linaclotide;   Drug: Placebo Sponsors:   Ironwood Pharmaceuticals, Inc.;   Allergan Sales, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2018 Category: Research Source Type: clinical trials

A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation
Condition:   Irritable Bowel Syndrome Characterized by Constipation Interventions:   Drug: Linaclotide;   Drug: Placebo Sponsors:   Ironwood Pharmaceuticals, Inc.;   Allergan Sales, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2018 Category: Research Source Type: clinical trials